Two Sigma Investments, LP Ocular Therapeutix, Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 207,421 shares of OCUL stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

207,421

Previous 536,119 61.31%

Holding current value

$1.66 Million

Previous $3.67 Million 50.8%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.45 - $9.23 $2.12 Million - $3.03 Million	-328,698 Reduced 61.31%	207,421 $1.8 Million
Q2 2024 Aug 14, 2024	BUY	$4.2 - $8.69 $2.17 Million - $4.49 Million	516,706 Added 2661.65%	536,119 $3.67 Million
Q1 2024 May 15, 2024	SELL	$3.85 - $10.93 $352,609 - $1 Million	-91,587 Reduced 82.51%	19,413 $176,000
Q4 2023 Feb 14, 2024	SELL	$2.08 - $4.52 $10,608 - $23,051	-5,100 Reduced 4.39%	111,000 $495,000
Q3 2023 Nov 14, 2023	SELL	$3.14 - $5.04 $63,428 - $101,808	-20,200 Reduced 14.82%	116,100 $364,000
Q2 2023 Aug 14, 2023	SELL	$4.6 - $7.64 $860,770 - $1.43 Million	-187,124 Reduced 57.86%	136,300 $703,000
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $374,805 - $842,305	134,339 Added 71.05%	323,424 $1.7 Million
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $22,641 - $38,256	-8,675 Reduced 4.39%	189,085 $531,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $808,838 - $1.29 Million	197,760 New	197,760 $821,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $1.45 Million - $2.52 Million	-483,284 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $64,808 - $98,622	13,418 Added 2.86%	483,284 $2.39 Million
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $2.62 Million - $5.14 Million	-425,534 Reduced 47.52%	469,866 $3.28 Million
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $1.36 Million - $2.02 Million	-140,645 Reduced 13.58%	895,400 $8.95 Million
Q2 2021 Aug 16, 2021	SELL	$13.43 - $19.16 $1.78 Million - $2.54 Million	-132,413 Reduced 11.33%	1,036,045 $14.7 Million
Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $3.93 Million - $5.49 Million	248,163 Added 26.97%	1,168,458 $19.2 Million
Q4 2020 Feb 16, 2021	BUY	$7.91 - $22.95 $4.67 Million - $13.5 Million	589,995 Added 178.62%	920,295 $19.1 Million
Q3 2020 Nov 16, 2020	BUY	$7.36 - $9.87 $1.04 Million - $1.4 Million	141,385 Added 74.84%	330,300 $2.51 Million
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $768,467 - $1.47 Million	164,554 Added 675.48%	188,915 $1.57 Million
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $96,225 - $180,271	24,361 New	24,361 $121,000
Q2 2019 Aug 14, 2019	SELL	$2.46 - $4.52 $75,613 - $138,931	-30,737 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$3.51 - $4.77 $138,448 - $188,147	-39,444 Reduced 56.2%	30,737 $122,000
Q4 2018 Feb 14, 2019	BUY	$3.87 - $7.11 $198,089 - $363,932	51,186 Added 269.47%	70,181 $279,000
Q3 2018 Nov 14, 2018	BUY	$5.42 - $6.99 $102,952 - $132,775	18,995 New	18,995 $131,000

Others Institutions Holding OCUL

# of Institutions

173

Shares Held

136M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $615M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Ocular Therapeutix, Inc Transaction History